# Assessment of SMS and Smartphone Interventions for OneTouch Reveal® Experiences

> **NCT02429024** · PHASE4 · COMPLETED · sponsor: **LifeScan** · enrollment: 138 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** OneTouch Reveal® Mobile APP
- **DEVICE:** OneTouch Verio® Flex BGMS

## Key facts

- **NCT ID:** NCT02429024
- **Lead sponsor:** LifeScan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2016-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02429024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02429024, "Assessment of SMS and Smartphone Interventions for OneTouch Reveal® Experiences". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02429024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*